Cargando…
DNA Methylation by Bisulfite Next-Generation Sequencing for MLH1 and MGMT in Oral Squamous Cell Carcinomas and Potentially Malignant Disorders: An Integrative Analysis towards Field Cancerization
Background and Objectives: MGMT methylation is a well-described biomarker in several solid tumors and MLH1 seems to occur in the initial stages of oral carcinogenesis. The aims of this study were to evaluate MHL1 and MGMT methylation levels in oral squamous cell carcinoma (OSCC) and oral potentially...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9322644/ https://www.ncbi.nlm.nih.gov/pubmed/35888599 http://dx.doi.org/10.3390/medicina58070878 |
_version_ | 1784756355715825664 |
---|---|
author | Padin-Iruegas, Elena Chamorro-Petronacci, Cintia M. Sines-Cajade, Iria Lorenzo-Pouso, Alejandro I. Blanco-Carrión, Andrés Pérez-Jardón, Alba Gándara-Vila, Pilar Pérez-Sayans, Mario |
author_facet | Padin-Iruegas, Elena Chamorro-Petronacci, Cintia M. Sines-Cajade, Iria Lorenzo-Pouso, Alejandro I. Blanco-Carrión, Andrés Pérez-Jardón, Alba Gándara-Vila, Pilar Pérez-Sayans, Mario |
author_sort | Padin-Iruegas, Elena |
collection | PubMed |
description | Background and Objectives: MGMT methylation is a well-described biomarker in several solid tumors and MLH1 seems to occur in the initial stages of oral carcinogenesis. The aims of this study were to evaluate MHL1 and MGMT methylation levels in oral squamous cell carcinoma (OSCC) and oral potentially malignant disorders (OPMDs), and to integrate this information with The Cancer Genome Atlas (TCGA) database. Materials and Methods: To determine the percentage of gene methylation in MLH1 and MGMT, pyrosequencing analysis was conducted. Samples were divided as follows: (1) patients diagnosed with OSCC (N = 16); (2) patients with OPDM who developed OSCC in the same location (N = 47); and (3) patients with OPDM who developed OSCC in a different location (N = 22). As a validation cohort in this study, data from The Cancer Genomic Atlas (TCGA) database, particularly regarding Head and Neck Squamous Cell Carcinoma, was used. Results: Overall MLH1 methylation levels of 8.6 ± 11.5% and 8.1 ± 9.2% for MGMT were obtained. With regard to MHL1, the OSCC presented the highest degree of methylation with 9.3 ± 7.3% (95%CI 5.1–13.6), and with regards to MGMT, the simultaneous malignancy group presented the highest degree of methylation with 10 ± 13.5% (95%CI 6–10), although no significant differences were found between the groups (p = 0.934 and p = 0.515, respectively). The estimated survival was higher for MGMT methylated cases (19.1 months, 95%CI 19.1–19.1) than for unmethylated cases (9.4 months, 95%CI 6–12.8), but not statistically significant. Conclusions: Our results did not show a correlation between MGMT and MLH1 methylation and any clinicopathological feature or survival in our institutional cohort. MLH1 methylation was present mainly in OSCC, whilst MGMT in OPMD represented a modest contribution to field cancerization, with an overall consistency with the TCGA database. |
format | Online Article Text |
id | pubmed-9322644 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-93226442022-07-27 DNA Methylation by Bisulfite Next-Generation Sequencing for MLH1 and MGMT in Oral Squamous Cell Carcinomas and Potentially Malignant Disorders: An Integrative Analysis towards Field Cancerization Padin-Iruegas, Elena Chamorro-Petronacci, Cintia M. Sines-Cajade, Iria Lorenzo-Pouso, Alejandro I. Blanco-Carrión, Andrés Pérez-Jardón, Alba Gándara-Vila, Pilar Pérez-Sayans, Mario Medicina (Kaunas) Article Background and Objectives: MGMT methylation is a well-described biomarker in several solid tumors and MLH1 seems to occur in the initial stages of oral carcinogenesis. The aims of this study were to evaluate MHL1 and MGMT methylation levels in oral squamous cell carcinoma (OSCC) and oral potentially malignant disorders (OPMDs), and to integrate this information with The Cancer Genome Atlas (TCGA) database. Materials and Methods: To determine the percentage of gene methylation in MLH1 and MGMT, pyrosequencing analysis was conducted. Samples were divided as follows: (1) patients diagnosed with OSCC (N = 16); (2) patients with OPDM who developed OSCC in the same location (N = 47); and (3) patients with OPDM who developed OSCC in a different location (N = 22). As a validation cohort in this study, data from The Cancer Genomic Atlas (TCGA) database, particularly regarding Head and Neck Squamous Cell Carcinoma, was used. Results: Overall MLH1 methylation levels of 8.6 ± 11.5% and 8.1 ± 9.2% for MGMT were obtained. With regard to MHL1, the OSCC presented the highest degree of methylation with 9.3 ± 7.3% (95%CI 5.1–13.6), and with regards to MGMT, the simultaneous malignancy group presented the highest degree of methylation with 10 ± 13.5% (95%CI 6–10), although no significant differences were found between the groups (p = 0.934 and p = 0.515, respectively). The estimated survival was higher for MGMT methylated cases (19.1 months, 95%CI 19.1–19.1) than for unmethylated cases (9.4 months, 95%CI 6–12.8), but not statistically significant. Conclusions: Our results did not show a correlation between MGMT and MLH1 methylation and any clinicopathological feature or survival in our institutional cohort. MLH1 methylation was present mainly in OSCC, whilst MGMT in OPMD represented a modest contribution to field cancerization, with an overall consistency with the TCGA database. MDPI 2022-06-30 /pmc/articles/PMC9322644/ /pubmed/35888599 http://dx.doi.org/10.3390/medicina58070878 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Padin-Iruegas, Elena Chamorro-Petronacci, Cintia M. Sines-Cajade, Iria Lorenzo-Pouso, Alejandro I. Blanco-Carrión, Andrés Pérez-Jardón, Alba Gándara-Vila, Pilar Pérez-Sayans, Mario DNA Methylation by Bisulfite Next-Generation Sequencing for MLH1 and MGMT in Oral Squamous Cell Carcinomas and Potentially Malignant Disorders: An Integrative Analysis towards Field Cancerization |
title | DNA Methylation by Bisulfite Next-Generation Sequencing for MLH1 and MGMT in Oral Squamous Cell Carcinomas and Potentially Malignant Disorders: An Integrative Analysis towards Field Cancerization |
title_full | DNA Methylation by Bisulfite Next-Generation Sequencing for MLH1 and MGMT in Oral Squamous Cell Carcinomas and Potentially Malignant Disorders: An Integrative Analysis towards Field Cancerization |
title_fullStr | DNA Methylation by Bisulfite Next-Generation Sequencing for MLH1 and MGMT in Oral Squamous Cell Carcinomas and Potentially Malignant Disorders: An Integrative Analysis towards Field Cancerization |
title_full_unstemmed | DNA Methylation by Bisulfite Next-Generation Sequencing for MLH1 and MGMT in Oral Squamous Cell Carcinomas and Potentially Malignant Disorders: An Integrative Analysis towards Field Cancerization |
title_short | DNA Methylation by Bisulfite Next-Generation Sequencing for MLH1 and MGMT in Oral Squamous Cell Carcinomas and Potentially Malignant Disorders: An Integrative Analysis towards Field Cancerization |
title_sort | dna methylation by bisulfite next-generation sequencing for mlh1 and mgmt in oral squamous cell carcinomas and potentially malignant disorders: an integrative analysis towards field cancerization |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9322644/ https://www.ncbi.nlm.nih.gov/pubmed/35888599 http://dx.doi.org/10.3390/medicina58070878 |
work_keys_str_mv | AT padiniruegaselena dnamethylationbybisulfitenextgenerationsequencingformlh1andmgmtinoralsquamouscellcarcinomasandpotentiallymalignantdisordersanintegrativeanalysistowardsfieldcancerization AT chamorropetronaccicintiam dnamethylationbybisulfitenextgenerationsequencingformlh1andmgmtinoralsquamouscellcarcinomasandpotentiallymalignantdisordersanintegrativeanalysistowardsfieldcancerization AT sinescajadeiria dnamethylationbybisulfitenextgenerationsequencingformlh1andmgmtinoralsquamouscellcarcinomasandpotentiallymalignantdisordersanintegrativeanalysistowardsfieldcancerization AT lorenzopousoalejandroi dnamethylationbybisulfitenextgenerationsequencingformlh1andmgmtinoralsquamouscellcarcinomasandpotentiallymalignantdisordersanintegrativeanalysistowardsfieldcancerization AT blancocarrionandres dnamethylationbybisulfitenextgenerationsequencingformlh1andmgmtinoralsquamouscellcarcinomasandpotentiallymalignantdisordersanintegrativeanalysistowardsfieldcancerization AT perezjardonalba dnamethylationbybisulfitenextgenerationsequencingformlh1andmgmtinoralsquamouscellcarcinomasandpotentiallymalignantdisordersanintegrativeanalysistowardsfieldcancerization AT gandaravilapilar dnamethylationbybisulfitenextgenerationsequencingformlh1andmgmtinoralsquamouscellcarcinomasandpotentiallymalignantdisordersanintegrativeanalysistowardsfieldcancerization AT perezsayansmario dnamethylationbybisulfitenextgenerationsequencingformlh1andmgmtinoralsquamouscellcarcinomasandpotentiallymalignantdisordersanintegrativeanalysistowardsfieldcancerization |